B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects

F Wu, J Gao, J Kang, X Wang, Q Niu, J Liu… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a common, chronic, systemic autoimmune disease, and its
clinical features are the proliferation of joint synovial tissue, the formation of pannus and the …

[HTML][HTML] Biological drug and drug delivery-mediated immunotherapy

Q Xiao, X Li, Y Li, Z Wu, C Xu, Z Chen, W He - Acta Pharmaceutica Sinica B, 2021 - Elsevier
The initiation and development of major inflammatory diseases, ie, cancer, vascular
inflammation, and some autoimmune diseases are closely linked to the immune system …

Regulatory B cells: TIM‐1, transplant tolerance, and rejection

A Cherukuri, K Mohib, DM Rothstein - Immunological reviews, 2021 - Wiley Online Library
Regulatory B cells (Bregs) ameliorate autoimmune disease and prevent allograft rejection.
Conversely, they hinder effective clearance of pathogens and malignancies. Breg activity is …

Anti-TNF therapy in spondyloarthritis and related diseases, impact on the immune system and prediction of treatment responses

S Menegatti, E Bianchi, L Rogge - Frontiers in immunology, 2019 - frontiersin.org
Immune-mediated inflammatory diseases (IMIDs), such as spondyloarthritis (SpA), psoriasis,
Crohn's disease (CD), and rheumatoid arthritis (RA) remain challenging illnesses. They …

Regulatory B cells in infection, inflammation, and autoimmunity

S Dasgupta, S Dasgupta, M Bandyopadhyay - Cellular immunology, 2020 - Elsevier
Regulatory B (Breg) cells are characterized by differential expression of CD5 and CD1d in
mouse and CD24 and CD38 in human immune systems. The Breg family also includes LAG …

Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors

KN Muth, J Rech, FO Losch, A Hoerning - Journal of Clinical Medicine, 2023 - mdpi.com
Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis,
peripheral and/or axial spondyloarthritis, Crohn's disease, and ulcerative colitis, are …

Transitional B cell cytokines predict renal allograft outcomes

A Cherukuri, AD Salama, R Mehta, K Mohib… - Science Translational …, 2021 - science.org
Early immunological biomarkers that predict rejection and chronic allograft loss are needed
to inform preemptive therapy and improve long-term outcomes. Here, we prospectively …

Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases

LI Sakkas, D Daoussis, A Mavropoulos… - Seminars in arthritis and …, 2019 - Elsevier
Abstract Objective Regulatory B cells (Bregs) are a new subset of B cells with
immunoregulatory functions, mainly through IL-10 production. Bregs suppress inflammatory …

B lymphocytes in rheumatoid arthritis and the effects of anti–TNF-α agents on B lymphocytes: a review of the literature

O Pala, A Diaz, BB Blomberg, D Frasca - Clinical therapeutics, 2018 - Elsevier
Purpose The aim of this article was to review published research related to B lymphocytes in
rheumatoid arthritis, their role in the pathogenesis of the disease, the effects of tumor …

Human B-cell subset identification and changes in inflammatory diseases

RL Velounias, TJ Tull - Clinical and experimental immunology, 2022 - academic.oup.com
Our understanding of the B-cell subsets found in human blood and their functional
significance has advanced greatly in the past decade. This has been aided by the evolution …